Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data
- PMID: 33842877
- PMCID: PMC8027118
- DOI: 10.3389/frai.2021.630955
Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data
Abstract
COVID-19, the illness caused by the SARS-CoV-2 virus, is now a worldwide pandemic with mortality in hundreds of thousands as infections continue to increase. Containing the spread of this viral infection and decreasing the mortality rate is a major challenge. Identifying appropriate antigenic epitopes from the viral proteins is a very important task for vaccine production and the development of diagnostic kits and antibody therapy. A novel antigenic epitope would be specific to the SARS-CoV-2 virus and can distinguish infections caused by common cold viruses. In this study two approaches are employed to identify both continuous and conformational B-cell antigenic epitopes. To achieve this goal, we modeled a complete structure of the receptor binding domain (RBD) of the spike protein using recently deposited coordinates (6vxx, 6vsb, and 6w41) in the protein data bank. In addition, we also modeled the RBD-ACE2 receptor complex for SARS-CoV-2 using the SARS-CoV RBD-ACE2 complex (3D0J) as a reference model. Finally, structure based predicted antigenic epitopes were compared to the ACE2 binding region of RBD of SARS-CoV-2. The identified conformational epitopes show overlaps with the ACE2-receptor binding region of the RBD of SARS-CoV-2. Strategies defined in the current study identified novel antigenic epitope that is specific to the SARS-CoV-2 virus. Integrating such approach in the diagnosis can distinguish infections caused by common cold viruses from SARS-CoV-2 virus.
Keywords: SARS–CoV−2; conformational epitope; receptor binding domian; spike protein; viral infection.
Copyright © 2021 Khare, Azevedo, Parajuli and Gokulan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures






Similar articles
-
Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein.Vaccines (Basel). 2021 Jul 28;9(8):829. doi: 10.3390/vaccines9080829. Vaccines (Basel). 2021. PMID: 34451954 Free PMC article.
-
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.Immunity. 2020 Jul 14;53(1):98-105.e5. doi: 10.1016/j.immuni.2020.06.001. Epub 2020 Jun 8. Immunity. 2020. PMID: 32561270 Free PMC article.
-
Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction.bioRxiv [Preprint]. 2020 Jul 31:2020.07.31.230730. doi: 10.1101/2020.07.31.230730. bioRxiv. 2020. Update in: Biophys J. 2021 Mar 16;120(6):1011-1019. doi: 10.1016/j.bpj.2021.02.007. PMID: 32766576 Free PMC article. Updated. Preprint.
-
COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.PLoS Pathog. 2020 Aug 21;16(8):e1008762. doi: 10.1371/journal.ppat.1008762. eCollection 2020 Aug. PLoS Pathog. 2020. PMID: 32822426 Free PMC article. Review.
-
Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein.J Clin Pathol. 2020 Jul;73(7):366-369. doi: 10.1136/jclinpath-2020-206658. Epub 2020 May 6. J Clin Pathol. 2020. PMID: 32376714 Review.
Cited by
-
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review.Vaccines (Basel). 2023 Jan 17;11(2):204. doi: 10.3390/vaccines11020204. Vaccines (Basel). 2023. PMID: 36851081 Free PMC article. Review.
-
Covid-19: virology, variants, and vaccines.BMJ Med. 2022 Apr 1;1(1):e000040. doi: 10.1136/bmjmed-2021-000040. eCollection 2022. BMJ Med. 2022. PMID: 36936563 Free PMC article. Review.
-
Evaluating the Antiviral Potential of Polyherbal Formulation (Kabasura Kudineer) Against Monkeypox Virus: Targeting E5, Poxin, and DNA Polymerase Through Multifaceted Drug Discovery Approaches.Life (Basel). 2025 May 12;15(5):771. doi: 10.3390/life15050771. Life (Basel). 2025. PMID: 40430198 Free PMC article.
-
Brewpitopes: a pipeline to refine B-cell epitope predictions during public health emergencies.Front Immunol. 2023 Dec 6;14:1278534. doi: 10.3389/fimmu.2023.1278534. eCollection 2023. Front Immunol. 2023. PMID: 38124749 Free PMC article.
-
Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?Life (Basel). 2022 Jan 28;12(2):194. doi: 10.3390/life12020194. Life (Basel). 2022. PMID: 35207482 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous